Nuwellis Q2 Revenue Jumps 14%, Gross Margin Hits 76% as Cash Runway Extends to 2027
NUWE is trading near its 52-week low of $1.345 (4.3% above the low) on light trading volume (0.1× avg).
Summary
Nuwellis reported Q2 2026 revenue of $2.0 million, up 14% year-over-year, with U.S. revenue up 17%. Gross margin improved to 76% from 56% a year ago, driven by pricing, product mix, and the shift to contract manufacturing. The company sold nine consoles in Q2 versus three last year, expanding the installed base for recurring circuit revenue. Recent capital raises and warrant exercises have extended the cash runway through Q2 2027, addressing going-concern risk. The FDA pre-submission meeting for Aquadex label expansion to patients 5kg and up is a notable regulatory milestone. This follows a series of dilutive financings and a 1-for-35 reverse split in June.
At the time of this announcement, NUWE was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $1.34 to $235.20. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.